19.60
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLP?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Simulations Plus Inc Aktie (SLP) Neueste Nachrichten
Simulations Plus, Inc. SEC 10-Q Report - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Bio-Techne (TECH) and Simulations Plus (SLP) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Q1 2026 Earnings Call Transcript - Insider Monkey
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales - TradingView — Track All Markets
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... By GuruFocus - Investing.com Canada
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Is Simulations Plus Inc. stock overvalued by current metricsJuly 2025 Closing Moves & Stepwise Swing Trade Plans - ulpravda.ru
Simulations Plus Q1 2026 Earnings Call Transcript - MarketBeat
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - PharmiWeb.com
Simulations Plus (SLP) Reports Q1 Revenue Aligning with Expectat - GuruFocus
Simulations Plus, Inc. Q1 Profit Increases, But Misses Estimates - Nasdaq
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast By Investing.com - Investing.com Nigeria
Simulations Plus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast - Investing.com
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline - Chartmill
Is Simulations Plus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - ulpravda.ru
Can Simulations Plus Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Capital Efficiency Focused Ideas - ulpravda.ru
Simulations Plus: Overview of First Quarter Financial Results - Bitget
Simulations Plus: Fiscal Q1 Earnings Snapshot - KVUE
SLP Adjusts FY26 Revenue Forecast Between $79M and $82M - GuruFocus
Simulations Plus Fiscal Q1 Adjusted EPS, Revenue Decrease - MarketScreener
Simulations Plus earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Simulations Plus Posts Mixed Q1 2026 Results, Reaffirms Outlook - TipRanks
Simulations Plus (NASDAQ:SLP) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS - MarketBeat
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat - Investing.com Nigeria
Simulations Plus Q1 revenue beats expectations - TradingView — Track All Markets
Simulations Plus, Inc. Reaffirms Earnings Guidance for Fiscal 2026 - MarketScreener
SLP: Analyst Maintains Rating and Raises Price Target to $19.00 - GuruFocus
Simulations Plus (NASDAQ:SLP) Price Target Raised to $19.00 - MarketBeat
Tributary Capital Management LLC Grows Stock Holdings in Simulations Plus, Inc. $SLP - MarketBeat
Will Simulations Plus Inc. stock benefit from green energy trendsMACD Trading Signals & Real-Life Case Studies You Can Follow - ulpravda.ru
An Overview of Simulations Plus's Earnings - Benzinga
North Star Investment Management Corp. Acquires 111,255 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Citizens maintains Simulations Plus stock rating ahead of earnings By Investing.com - Investing.com Canada
Simulations Plus Q1 2025 Earnings Preview - MSN
Simulations Plus drives advancements in CAR-T therapy kinetics - Traders Union
What drives Simulations Plus Inc stock priceTrading Volume Trends & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat By Investing.com - Investing.com Nigeria
Simulations Plus (SLP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Signal Recap: Will Simulations Plus Inc stock outperform Nasdaq indexJuly 2025 Chart Watch & AI Optimized Trade Strategies - moha.gov.vn
Simulations Plus (NASDAQ: SLP) details 2026 meeting, auditor and equity plan votes - Stock Titan
Simulations Plus (FRA:SD3) Intrinsic Value: Projected FCF : €10.77 (As of Dec. 27, 2025) - GuruFocus
Guidance Update: Is PCGPRH stock overvalued by current metricsJuly 2025 PreEarnings & Low Volatility Stock Suggestions - moha.gov.vn
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Simulations Plus (SLP) Highlights FDA Alignment as Citizens Maintains Market Perform - Insider Monkey
Diluted shares outstanding of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Current ratio of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Can Simulations Plus Inc. stock deliver strong Q4 earnings2025 Historical Comparison & High Return Stock Watch Alerts - DonanımHaber
Will Simulations Plus Inc. stock attract more institutional investorsQuarterly Profit Report & Weekly Top Gainers Trade List - DonanımHaber
Trading Recap: Will Simulations Plus Inc. stock benefit from green energy trendsMarket Sentiment Report & Fast Gaining Stock Reports - Улправда
Simulations Plus (SLP) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Will Simulations Plus Inc. stock maintain growth story2025 Institutional Moves & Daily Market Momentum Tracking - Улправда
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):